Status:

SUSPENDED

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Lead Sponsor:

Azidus Brasil

Conditions:

Covid-19

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

This is an exploratory study to evaluate the efficacy of hydroxychloroquine (400 mg BID on D1 and 400 mg/day on D2 to D7) and azithromycin (500 mg/ 5 days) to treat mild ambulatory COVID-19 patients.

Detailed Description

This is an exploratory study to evaluate the efficacy of hydroxychloroquine (400 mg BID on D1 and 400 mg/day on D2 to D7) and azithromycin (500 mg/ 5 days) to treat mild ambulatory COVID-19 patients. ...

Eligibility Criteria

Inclusion

  • Informed consent from patient or legal representative.
  • Male or female, and:
  • aged ≥ 70 years; or
  • aged \< 70 with associated risk factors (chronic obstructive pulmonary disease; heart failure, immunosuppressed, obesity (BMI ≥ 35) uncontrolled diabetes and uncontrolled systemic arterial hypertension)
  • One or more mild symptoms characteristic of COVID-19 for 3 days, such as fever, cough and signs of respiratory distress, which do not require hospitalization.

Exclusion

  • Participating in another RCT in the past 12 months;
  • Known allergy to HCQ or chloroquine
  • Any contraindication to HTC or AZT, including retinopathy and prolonged QT,
  • Severely reduced LV function
  • Severely reduced renal function;
  • Pregnancy or breast feeding
  • Any other clinical condition which, in the opinion of the principal investigator, would not allow safe completion of the protocol and safe administration of the investigational products

Key Trial Info

Start Date :

April 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2023

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04348474

Start Date

April 20 2020

End Date

July 1 2023

Last Update

November 4 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prevent Senior Private Operadora de Saúde LTDA.

São Paulo, Brazil